Rockwell Automation Teams with IBM to Deliver Value-Driven Compliance Solutions to Life Sciences Companies | Automation.com

Rockwell Automation Teams with IBM to Deliver Value-Driven Compliance Solutions to Life Sciences Companies

April 262005
MILWAUKEE, April 26, 2005 — Rockwell Automation today announced that it will be teaming with IBM Health Care and Life Sciences to deliver manufacturing technology and expertise as part of the IBM Value-Driven Compliance Solutions framework. Working with Rockwell Automation and IBM, pharmaceutical companies will be able to identify and capture opportunities to reduce risk and increase operational efficiencies.

Rockwell Automation, IBM and other Value-Driven Compliance Solutions partners have created a Proof-of-Concept demonstrating how life sciences manufacturers can use the power of information integration to identify revenue opportunities and cost efficiencies in a real-time manufacturing environment.

“Rockwell Automation has significantly complemented our point of view and added key manufacturing elements to our science-based approach for reducing [email protected],”
said Doug Dean, senior executive, Global Quality and Value-Driven Compliance, IBM Healthcare and Life Sciences. “The IBM Proof-of-Concept is the first demonstration of how complex solutions can be integrated with a compliance-centric architecture to transform a pharmaceutical organization’s development and manufacturing processes.”

IBM’s Value-Driven Compliance Solutions framework is an initiative designed to help pharmaceutical companies improve manufacturing efficiencies, comply with systems-based regulations and increase top-line growth. IBM is teaming with leading solution providers, including Rockwell Automation, to transform the development, manufacturing and supply chain asset base of large pharmaceutical and bio-tech manufacturers from a process-based to a science-based approach. This science-based approach helps manufacturers comply with government regulations by focusing on designing quality into the manufacturing process as opposed to post-manufacturing inspection.

“Over 95 percent of Fortune 50 pharmaceutical companies use Rockwell Automation solutions to optimize their manufacturing, assist with regulatory compliance and achieve a complete enterprise-wide view of information from manufacturing control systems,” said Bob Honor, vice president of life sciences, Rockwell Automation. “This partnership will better enable life sciences companies to turn manufacturing information into knowledge, so they can make the right business decisions.”

Life sciences companies can learn more about reducing risk and increasing manufacturing efficiency through the IBM Value-Driven Compliance Solutions at upcoming Rockwell Automation events. For more information please visit www.rockwellautomation.com/lifesciences.

IBM Healthcare and Life Sciences brings together IBM resources, from information technology to deep industry insights and research expertise, to help clients transform the development and delivery of safer, more affordable and more effective diagnostics, drugs and medical care. The fastest way to get more information about IBM Healthcare and Life Sciences is through its Web site, www.ibm.com/lifesciences.

Rockwell Automation (NYSE: ROK), is a leading global provider of automation, power, control, and information solutions that help manufacturers achieve a competitive advantage in their businesses. Headquartered in Milwaukee, Wis., U.S.A., the company employs about 20,000 people serving customers in more than 80 countries.
Back to top
Company Portal: 
Rockwell Automation


Posted in:
Industry

MORE INDUSTRY NEWS

VIEW ALL

RELATED